7-(3-CHLOROPHENYL)-3-(4-METHOXYPHENYL)THIENO[3,2-D]PYRIMIDIN-4(3H)-ONE

Catalog No. :
ACLSID052
CAS No. :
1621967-40-5
Molecular Formula :
C19H13ClN2O2S
Molecular Weight :
368.85

IUPAC Name:7-(3-chlorophenyl)-3-(4-methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one

7-(3-CHLOROPHENYL)-3-(4-METHOXYPHENYL)THIENO[3,2-D]PYRIMIDIN-4(3H)-ONE structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$451.00Login to see priceInquiryInquiry
1g95%$1127.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-(3-CHLOROPHENYL)-3-(4-METHOXYPHENYL)THIENO[3,2-D]PYRIMIDIN-4(3H)-ONE
IUPAC Name7-(3-chlorophenyl)-3-(4-methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one
MDL No.MFCD31556034
Molecular FormulaC19H13ClN2O2S
Molecular Weight368.85
SMILESO=C1C2=C(N=CN1C3=CC=C(C=C3)OC)C(C4=CC=CC(Cl)=C4)=CS2
InChI KeyGUTRXWJLDDQWFA-UHFFFAOYSA-N
Synonym7-(3-Chlorophenyl)-3-(4-methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one;Thieno[3,2-d]pyrimidin-4(3H)-one, 7-(3-chlorophenyl)-3-(4-methoxyphenyl)-
CAS No.1621967-40-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACLSID052 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNSOE016 route compound structure diagram
    ACNSOE01663503-60-6 In Stock
  4. Then
  5. ACLSID052 route product structure diagram
    ACLSID0521621967-40-5
Inquiry

2. ACLSID052 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFPSA972 route compound structure diagram
    ACFPSA9725720-07-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLSID052 route product structure diagram
    ACLSID0521621967-40-5
Inquiry

Comments (0)